Bioprocessing - Upstream & Downstream

Why is there a need for innovation in cell line development technology?

Nominations are now open for The Medicine Maker 2021 Innovation Awards.

Is there data demonstrating significant cost benefits from continuous biomanufacturing?

How do we choose the right bioprocessing technologies for the short and long term?

We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.

Watch our video interview with Maik Jornitz.

To speed up vaccine development, we need to assess our bioconjugation approaches.

Biopharma companies are rapidly making changes to their manufacturing strategies – and flexible downstream unit operation solutions are key.

How adding barcodes to glass containers can improve traceability.

A 70-year-old technique is helping to cut the development costs of monoclonal antibodies.